Omenn syndrome: A disorder of RAG1 and RAG2 genes

Journal of Clinical Immunology

Volumn 19, Issue 2, 1999, Pages 87-97

  Villa, Anna ^a   Santagata, Sandro ^b   Bozzi, Fabio ^a   Imberti, Luisa ^c   Notarangelo, Luigi D ^d  

^a CNR   (Italy)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c SPEDALI CIVILI   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Omenn syndrome; Rag genes; Severe combined immune deficiency; V(D)J recombination

Indexed keywords

CYTOKINE; T LYMPHOCYTE RECEPTOR;

ARTICLE; COMBINED IMMUNODEFICIENCY; FRAMESHIFT MUTATION; GENE ISOLATION; GENE REARRANGEMENT; HUMAN; IMMUNOPATHOGENESIS; LYMPHOPOIESIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0032941208     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020550432126     Document Type: Article

References (70)

1. 1. Agrawal A, Eastman Q, Schatz D: Transposition mediated by Rag1 and Rag2 and its implications for the evolution of the immune system. Nature 394:744-751, 1998
2. 2. Hiom K, Melek M, Gellert M: Dna transposition by the Rag1 and Rag2 proteins: A possible source of oncogenic translocations. Cell 94:463-470, 1998
3. 3. Tonegawa S: Somatic generation of antibody diversity. Nature 302:575-581, 1983
4. 4. Lewis SM: The mechanism of V(D)J joining: Lessons from molecular, immunological and comparative analyses. Adv Immunol 56:27-150, 1994
5. 5. Hesse JE, Lieber MR, Mizuuchi K, Gellert M: V(D)J recombination: A functional definition of the joining signals. Genes Dev 3:1053-1061, 1989
6. 6. Ramsden DA, Baetz K, Wu GE: Conservation of sequence in recombination signal sequence spacers. Nucleic Acids Res 22: 1785-1796, 1994
7. 7. McBlane JF, van Gent DC, Ramsden DA, Romeo C, Cuomo CA, Gellert M, Oettinger MA: Cleavage at a V(D)J recombination signal requires only Rag1 and Rag2 proteins and occurs in two steps. Cell 83:387-395, 1995
8. 8. van Gent DC, McBlane JF, Ramsden DA, Sadofsky MJ, Hesse JE, Gellert M: Initiation of V(D)J recombination in a cell-free system. Cell 81:925-934, 1995
9. 9. Sawchuk DJ, Weis-Garcia F, Malik S, Besmer E, Bustin M, Nussenzweig MC, Cortes P: V(D)J recombination: modulation of Rag1 and Rag2 cleavage activity on 12/23 substrates by whole cell extract and DNA bending proteins. J Exp Med 185:2025-2032, 1997
10. 10. van Gent D C, Hiom K, Paull TT, Gellert M: Stimulation of V(D)J cleavage by high mobility group proteins. EMBO J 16:2665-2670, 1997
11. 11. Besmer E, Mansilla-Soto J, Cassard S, Sawchuck DJ, Brown G, Sadofsky M, Lewis SM, Nussenzweig MC, Cortes P: Hairpin coding end opening is mediated by the recombination activating genes Rag1 and Rag2. Mol Cell 2:817-828, 1998
12. 12. Landau NR, Schatz DG, Rosa M, Baltimore D: Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector. Mol Cell Biol 7:3237-3243, 1987
13. 13. Jackson SP, Jeggo PA: DNA double strand break repair and V(D)J recombination: Involvement of DNA-PK. Trends Biochem Sci 20:412 415, 1995
14. 14. Bogue M, Roth DB: Mechanism of V(D)J recombination. Curr Opin Immunol 8:175-180, 1996
15. 15. Agrawal A, Schatz DG: Rag1 and Rag2 form a stable postcleavage complex with DNA containing signal ends in V(D)J recombination. Cell 89:43-53, 1997
16. 16. Zhu C, Bogue MA, Lim DS, Hasty P, Roth DB: Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86:379-390, 1996
17. 17. Bogue MA, Wang C, Zhu C, Roth DB: V(D)J recombination in Ku86-deficient mice: Distinct effects on coding, signal and hybrid joint formation. Immunity 7:37-47, 1997
18. 18. Gu Y, Seidl KJ, Rathbun GA, Zhu C, Manis JP, van der Stoap N, Davidson L, Cheng HL, Sekiguchi JM, Frank K, Stanhope-Baker P, Schliesel M, Roth DB, Alt FW: Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity 7:853-865, 1997
19. 19. Taccioli GE, Amatucci AG, Gell D, Xiang X, Arzayus T, Pristley A, Jackson SP, Rothstein AM, Jeggo PA, Herrera VLM: Targeted disruption of the catalytic subunit of the Dna-Pk gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity 9:355-366, 1998
20. 20. Gao Y, Chaudhuri J, Zhu C, Davidson L, Weaver D, Alt FW: A targeted Dna-Pkcs-null mutation reveals Dna-Pk-independent functions for Ku in V(D)J recombination. Immunity 9:367-376, 1998
21. 21. Grawunder U, Wilm M, Wu X, Kulesza P, Wilson TE, Mann M, Lieber MR: Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 388: 492-495, 1997
22. 22. Schatz DG, Oettinger MA, Baltimore D: The V(D)J recombination activating gene Rag1. Cell 59:1035-1048, 1989
23. 23. Oettinger MA, Schatz DG, Gorka C, Baltimore D: Rag1 and Rag2, adjacent genes that synergistically activate V(D)J recombination. Science 248:1517-1523, 1990
24. 24. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: Rag1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877, 1992
25. 25. Shinkai Y, Rathbun G, Lam K-P, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, Alt F: Rag2-deficient mice lack mature lymphocytes owing to inability to initiate V(D) rearrangement. Cell 68:855-867, 1992
26. 26. Oettinger MA, Stanger B, Schatz DG, Glaser T, Call K, Housman D, Baltimore D: The recombination activating genes, Rag1 and Rag2, are on chromosome 11p in humans and chromosome 2p in mice. Immunogenetics 35:97-101, 1992
27. 27. Bernstein RM, Schluter SF, Bernstein H, Marchalonis JJ: Primordial emergence of the recombination activating gene 1 (Rag1): Sequence of the complete shark gene indicates homology to microbial integrases. Proc. Natl. Acad. Sci. USA 93:9454-9459, 1996
28. 28. Zarrin AA, Fong I, Malkin L, Marsden P, Berinstein NL: Cloning and characterization of the human recombination activating gene 1 (Rag1) and Rag2 promoter regions. J Immunol 159:4382-4394, 1997
29. 29. Spanopoulou E, Cortes P, Huang E, Shih C, Silver D, Svec P, Baltimore D: Localization, interaction and RNA-binding properties of the V(D)J recombination activating proteins Rag1 and Rag2. Immunity 3:715-726, 1995
30. 30. Mc Mahan CJ, Difilippantonio MJ, Rao N, Spanopoulou E, Schatz DG: A basic motif in the N-terminal region of Rag1 enhances V(D)J recombination activity. Mol Cell Biol 17:4544-4552, 1997
31. -/- B cells reveals a requirement for novel elements in the N-terminus of Rag1. Immunity 7:13-24, 1997
32. 32. McMahan CJ, Sadofsky MJ, Schatz DG: Definition of a large region of Rag1 that is important for coimmunoprecipitation of Rag2. J Immunol 158:2202-2210, 1997
33. 33. Cuomo CA, Kirch SA, Gyeris J, Brent R, Oettinger MA: Rch1, a protein that specifically interacts with the Rag1 recombination activating protein. Proc Natl Acad Sci USA 91:6156-6160, 1994
34. 34. Sadofsky MJ, Hesse JE, McBlane JF, Gellert M: Expression and V(D)J recombination activity of mutated Rag1 proteins. Nucleic Acids Res 21:5644-5650, 1993
35. 35. Spanopoulou E, Zaitseva F, Wang F-H, Santagata S, Baltimore D, Panayotou G: The homeodomain region of Rag1 reveals the parallel mechanisms of bacterial and V(D)J recombination. Cell 87:263-276, 1996
36. 36. Difilippantonio M, McMahan CJ, Eastman QM, Spanopoulou E, Schatz DG: Rag-1 mediates signal sequence recognition and recruitment of Rag-2 in V(D)J recombination. Cell 87:253-262, 1996
37. 37. Hiom K, Gellert M: A stable Rag1-Rag2-DNA complex that is active in V(D)J cleavage. Cell 88:65-72, 1997
38. 38. Desiderio S, Lin WC, Li Z: The cell cycle and V(D)J recombination. Curr Top Microbiol Immunol 217:45-59, 1996
39. 39. Hikida M, Mori M, Takai T, Tomochika K, Hamatani K, Ohmorí H: Reexpression of Rag1 and Rag2 genes in activated mature mouse B cells. Science 274:2092-2094, 1996
40. 40. Han S, Zheng B, Schatz DG, Spanopoulou E, Kelsoe G: Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science 274:2094-2097, 1997
41. 41. Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W, Seger RA, Hansen-Hagge TE, Desiderio S, Lieber MR, Bartram CR: Rag mutations in human B cell-negative SCID. Science 274:97-99, 1996
42. 42. Nicolas N, Moshous D, Cavazzana-Calvo M, Papadopoulo D, de Chasseval R, Le Deist F, Fischer A, de Villartay J-P: A human severe combined immunodeficiency (SCID) condition with increased sensitivity to ionizing radiations and impaired V(D)J rearrangemen ts defines a new DNA recombination/repair deficiency. J Exp Med 188:627-634, 1998
43. 43. Cavazzana-Calvo M, Le Deist F, de Saint Basile G, Papadopoulo D, De Villartay JP, Fisher A: Increased radiosensitivity of granulocyte macrophage colony-forming units and skin fibroblasts in human autosomal recessive severe combined immunodeficiency. J Clin Invest 91:1214-1218, 1993
44. 44. Blunt T, Finnie NJ, Taccioli GE, Smith GC.M, Demengeot J, Gottlieb TM, Mizuta R, Varghese AJ, Alt FW, Jeggo PA, Jackson SP: Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the mur ine scid mutation. Cell 80:813-823, 1995
45. 45. Blunt T, Gell D, Fox M, Taccioli GE, Lehmann AR, Jackson SP, Jeggo PA: Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc Natl Acad Sci USA 93:10285-10290, 1996
46. 46. Danska JS, Holland DP, Mariathasa S, Williams, Guidos CJ: Biochemical and genetic defects in the DNA-dependent protein kinase in murine scid lymphocytes. Mol Cell Biol 16:5507-5517, 1996
47. 47. Araki R, Fujimori A, Hamatani K, Mita K, Saito T, Mori M, Fukumura R, Morimyo M, Muto M, Itoh M, Tatsumi K, Abe M: Non-sense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. Proc Natl Acad Sci USA 94:2438-2443, 1997
48. 48. Omenn GS: Familial reticuloendotheliosis with eosinophilia. N Engl J Med 273:427-432, 1965
49. 49. Le Deist F, Fischer, Durandy A, Arnaud-Battandier F, Nezelof C, Hamet M, De Prost Y, Griscelli C: Déficit immunitaire mixte et grave avec hyperéosinophilie. Arch Fr Pediatr 42:11-16, 1985
50. 50. Pollack MS, Kirkpatrick D, Kapoor N, Dupont B, O'Reilly RJ: Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 307:662-666, 1982
51. 51. Le Deist F, Raffoux C, Griscelli C, Fischer A: Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation. J Immunol 138:423-427, 1987
52. 52. Ochs HD, Davis SD, Mickelson E, Lerner KG, Wedgwood RJ: Combined immunodeficiency and reticuloendotheliosis with eosinophilia. J Pediatr 85:463-465, 1974
53. 53. Brugnoni D, Airò P, Facchetti F, Blanzuolí L, Ugazio AG, Cattaneo R, Notarangelo LD: In vitro cell death of activated lymphocytes in Omenn's syndrome. Eur J Immunol 27:2765-2773, 1997
54. 54. Martin JV, Willoughby PB, Giusti V, Price G, Cerezo L: The lymph node pathology of Omenn's syndrome. Am J Surg Pathol 19:1082-1087, 1995
55. 55. Chilosi M, Pizzolo G, Facchetti F, Notarangelo LD, Romagnani S, Del Prete G, Almerigogna F, De Carli M: The pathology of Omenn's syndrome. Am J Surg Pathol 20:773-774, 1996
56. 56. Schandené L, Ferster A, Mascart-Lemone F, Crusiaux A, Grard C, Marchant A, Lybin M, Velu T, Sariban E, Goldman M: T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol 23:56-60, 1993
57. 57. Wirt DP, Brooks EG, Vaidya S, Klimpel GR, Waldmann TA, Goldblum RM: Novel T-lymphocyte population in combined immunodeficiency with features of graft-versus-host disease. N Engl J Med 321:370-374, 1989
58. 58. Chilosi M, Facchetti F, Notarangelo LD, Romagnani S, Del Prete G, Almerigogna F, De Carli M, Pizzolo G: CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated acondition. Eur J Immunol 26:329-334, 1996
59. 59. Harville TO, Adams DM, Howard TA, Ware RE: Oligoclonal expansion of CD45R0+ T lymphocytes in Omenn syndrome. J Clin Immunol 17:322-332, 1997
60. 60. Rieux-Laucat F, Bahadoran P, Brousse N, Selz F, Fischer A, Le Deist F, dE Villartay JP: Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome. J Clin Invest 102:312-321, 1998
61. 61. Villa A, Santagata S, Bozzi F, Frattini A, Imberti L, Benerini Gatta L, Ochs HD, Schwarz K, Notarangelo LD, Vezzoni P, Spanopoulou E: Partial V(D)J recombination activity leads to Omenn syndrome. Cell 93:885-896, 1998
62. 62. Gomez L, Le Deist F, Blanche S, Cavazzana-Calvo M, Griscelli C, Fischer A: Treatment of Omenn syndrome by bone marrow transplantation. J Pediatr 127:76-81, 1995
63. 63. de Saint-Basile G, Le Deist F, de Villartay JP, Cerf-Bensussan N, Journet O, Brousse N, Griscelli C, Fischer A: Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). J Clin Invest 87:1352-1359, 1991
64. 64. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549, 1993
65. 65. Hosken NA, Shibuya K, Heath AW, Murphy KM, O'Garra A: The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha and beta-transgenic model. J Exp Med 182:1579-1584, 1995
66. 66. Kaplan MH, Sun Y-L, Hoey T, Grusby MJ: Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174-177, 1996
67. 67. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA, Gately MK: IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 5:471-481, 1996
68. 68. Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G: Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 26:1553-1559, 1996
69. 69. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DAA, Doherty PC, Grosveld GC, Ihle JN: Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171-174, 1996
70. 70. Nadel B, Tang A, Escuro G, Lugo G, Feeney AJ: Sequence of the spacer in the recombination signal sequence affects V(D)J rearrangement frequency and correlates with nonrandom Vk usage in vivo. J Exp Med 187:1495-1503, 1998